Scientists at Stanford University have developed an innovative intranasal vaccine that could revolutionize the fight against respiratory diseases. Tests conducted on animals have shown the preparation's effectiveness in protecting against influenza, COVID-19, colds, and even dust mite allergies. The new spray administration method significantly differs from traditional vaccinations, offering broad protection lasting several months and eliminating the need for frequent injections.
Researchers from Stanford Medicine have published the results of their study on a universal intranasal vaccine in the prestigious journal „Science”. This preparation represents a radical departure from the vaccination paradigm used since the time of Edward Jenner. Traditional vaccines teach the body to recognize a specific pathogen, while the new formula is designed to provide broad protection against a whole range of threats – from viruses to bacteria causing sepsis <przypis title=